Concepts (144)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lung Diseases, Interstitial | 2 | 2024 | 918 | 0.930 |
Why?
|
Graft vs Host Disease | 5 | 2024 | 3026 | 0.830 |
Why?
|
Connective Tissue Diseases | 1 | 2024 | 285 | 0.740 |
Why?
|
Immune System Diseases | 1 | 2023 | 254 | 0.730 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2023 | 386 | 0.660 |
Why?
|
Mesenchymal Stem Cells | 2 | 2021 | 1643 | 0.630 |
Why?
|
Eosinophilia | 1 | 2023 | 557 | 0.620 |
Why?
|
Opportunistic Infections | 1 | 2021 | 376 | 0.600 |
Why?
|
Interleukin-2 | 1 | 2023 | 1891 | 0.540 |
Why?
|
Immunocompromised Host | 1 | 2021 | 858 | 0.500 |
Why?
|
Hematopoietic Stem Cell Transplantation | 3 | 2022 | 5667 | 0.460 |
Why?
|
Biological Products | 1 | 2023 | 913 | 0.450 |
Why?
|
Regenerative Medicine | 2 | 2017 | 306 | 0.430 |
Why?
|
Transplantation Conditioning | 1 | 2020 | 1591 | 0.420 |
Why?
|
Lung Diseases | 1 | 2023 | 1909 | 0.420 |
Why?
|
Spectrometry, Fluorescence | 2 | 2012 | 684 | 0.420 |
Why?
|
Tissue Engineering | 3 | 2019 | 1865 | 0.390 |
Why?
|
Leadership | 1 | 2021 | 1386 | 0.380 |
Why?
|
Metabolome | 1 | 2018 | 989 | 0.370 |
Why?
|
Immunity, Innate | 1 | 2022 | 3044 | 0.340 |
Why?
|
Interferon-gamma | 1 | 2018 | 3155 | 0.330 |
Why?
|
Immunosuppressive Agents | 1 | 2021 | 4189 | 0.300 |
Why?
|
Proteome | 1 | 2018 | 1856 | 0.300 |
Why?
|
Macrophage Activation Syndrome | 2 | 2024 | 124 | 0.260 |
Why?
|
Membrane Proteins | 1 | 2022 | 7844 | 0.250 |
Why?
|
OX40 Ligand | 1 | 2024 | 57 | 0.240 |
Why?
|
DNA | 2 | 2022 | 7189 | 0.230 |
Why?
|
Schwann Cells | 2 | 2015 | 196 | 0.210 |
Why?
|
Child | 11 | 2024 | 80134 | 0.210 |
Why?
|
Familial Mediterranean Fever | 1 | 2022 | 65 | 0.200 |
Why?
|
Antigen-Presenting Cells | 1 | 2024 | 965 | 0.180 |
Why?
|
Quantum Dots | 2 | 2012 | 167 | 0.180 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2024 | 3092 | 0.170 |
Why?
|
Nanoparticles | 1 | 2012 | 1959 | 0.170 |
Why?
|
Nucleotidyltransferases | 1 | 2022 | 242 | 0.170 |
Why?
|
Lung Transplantation | 3 | 2019 | 1307 | 0.170 |
Why?
|
Cross Circulation | 1 | 2019 | 11 | 0.170 |
Why?
|
Interferon Type I | 1 | 2023 | 557 | 0.170 |
Why?
|
Lung | 4 | 2022 | 9979 | 0.170 |
Why?
|
Interleukin-1 | 1 | 2023 | 1250 | 0.160 |
Why?
|
Organizational Innovation | 1 | 2021 | 538 | 0.150 |
Why?
|
Child, Preschool | 5 | 2024 | 42217 | 0.140 |
Why?
|
Exanthema | 1 | 2022 | 503 | 0.140 |
Why?
|
Bioengineering | 1 | 2017 | 99 | 0.140 |
Why?
|
Ondansetron | 1 | 2016 | 95 | 0.130 |
Why?
|
Humans | 24 | 2024 | 761098 | 0.130 |
Why?
|
Organ Preservation | 1 | 2019 | 382 | 0.130 |
Why?
|
Cell Hypoxia | 1 | 2018 | 656 | 0.130 |
Why?
|
CD4 Lymphocyte Count | 1 | 2021 | 2569 | 0.120 |
Why?
|
Glucocorticoids | 1 | 2024 | 2160 | 0.120 |
Why?
|
Gastroenteritis | 1 | 2016 | 236 | 0.120 |
Why?
|
Perfusion | 1 | 2019 | 1390 | 0.120 |
Why?
|
Bioreactors | 1 | 2015 | 246 | 0.110 |
Why?
|
Anemia, Sickle Cell | 1 | 2022 | 1063 | 0.110 |
Why?
|
Retrospective Studies | 7 | 2024 | 80673 | 0.110 |
Why?
|
Incidence | 2 | 2023 | 21357 | 0.110 |
Why?
|
Bioartificial Organs | 1 | 2013 | 47 | 0.110 |
Why?
|
Adolescent | 6 | 2024 | 88271 | 0.110 |
Why?
|
Vomiting | 1 | 2016 | 651 | 0.110 |
Why?
|
Infant | 4 | 2024 | 36164 | 0.110 |
Why?
|
Complex Mixtures | 1 | 2012 | 29 | 0.110 |
Why?
|
Risk Factors | 5 | 2024 | 74219 | 0.100 |
Why?
|
Regeneration | 2 | 2019 | 1505 | 0.100 |
Why?
|
Neurotrophin 3 | 1 | 2012 | 61 | 0.100 |
Why?
|
Autoimmune Diseases | 1 | 2024 | 2243 | 0.100 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2024 | 2157 | 0.100 |
Why?
|
Cell Survival | 2 | 2018 | 5776 | 0.090 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2016 | 1331 | 0.090 |
Why?
|
Macromolecular Substances | 1 | 2012 | 1429 | 0.090 |
Why?
|
Extracellular Matrix | 2 | 2017 | 1720 | 0.080 |
Why?
|
Pluripotent Stem Cells | 1 | 2016 | 792 | 0.080 |
Why?
|
Administration, Oral | 1 | 2016 | 4014 | 0.080 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2019 | 1850 | 0.070 |
Why?
|
Cell Separation | 1 | 2013 | 1718 | 0.070 |
Why?
|
Immunotherapy | 1 | 2023 | 4642 | 0.070 |
Why?
|
Heart Defects, Congenital | 1 | 2024 | 4673 | 0.070 |
Why?
|
Arthritis, Rheumatoid | 1 | 2023 | 3754 | 0.070 |
Why?
|
Myocardium | 1 | 2019 | 4746 | 0.070 |
Why?
|
Cells, Cultured | 2 | 2018 | 18926 | 0.060 |
Why?
|
Transfection | 1 | 2012 | 5750 | 0.060 |
Why?
|
Case-Control Studies | 1 | 2021 | 22157 | 0.050 |
Why?
|
Interleukin-15 | 1 | 2023 | 185 | 0.050 |
Why?
|
HLA-DR Antigens | 1 | 2023 | 606 | 0.050 |
Why?
|
Colchicine | 1 | 2022 | 258 | 0.050 |
Why?
|
Models, Biological | 1 | 2016 | 9455 | 0.040 |
Why?
|
Follow-Up Studies | 1 | 2021 | 39121 | 0.040 |
Why?
|
Signal Transduction | 1 | 2022 | 23415 | 0.040 |
Why?
|
Feasibility Studies | 2 | 2024 | 5249 | 0.040 |
Why?
|
Tissue Scaffolds | 2 | 2017 | 932 | 0.040 |
Why?
|
Inflammation | 1 | 2018 | 10758 | 0.040 |
Why?
|
Male | 5 | 2024 | 360675 | 0.040 |
Why?
|
Phenotype | 1 | 2015 | 16572 | 0.040 |
Why?
|
Female | 6 | 2024 | 392458 | 0.040 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2023 | 976 | 0.040 |
Why?
|
Age of Onset | 1 | 2024 | 3307 | 0.040 |
Why?
|
Forkhead Transcription Factors | 1 | 2024 | 1612 | 0.040 |
Why?
|
Swine, Miniature | 1 | 2019 | 961 | 0.030 |
Why?
|
Young Adult | 1 | 2023 | 59199 | 0.030 |
Why?
|
Swine | 2 | 2019 | 5909 | 0.030 |
Why?
|
Tissue and Organ Harvesting | 1 | 2019 | 373 | 0.030 |
Why?
|
Antibodies | 1 | 2023 | 2415 | 0.030 |
Why?
|
Antiemetics | 1 | 2016 | 186 | 0.030 |
Why?
|
Respiratory Mucosa | 1 | 2017 | 436 | 0.030 |
Why?
|
Autoantibodies | 1 | 2023 | 2117 | 0.030 |
Why?
|
Transplantation, Homologous | 1 | 2022 | 4822 | 0.030 |
Why?
|
Lymphocyte Activation | 1 | 2024 | 5478 | 0.030 |
Why?
|
Muscle, Smooth | 1 | 2017 | 927 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2017 | 2468 | 0.030 |
Why?
|
Fluid Therapy | 1 | 2016 | 578 | 0.030 |
Why?
|
Tensile Strength | 1 | 2013 | 330 | 0.030 |
Why?
|
Polypropylenes | 1 | 2012 | 62 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2019 | 1662 | 0.020 |
Why?
|
Elastin | 1 | 2013 | 298 | 0.020 |
Why?
|
Dendrimers | 1 | 2012 | 73 | 0.020 |
Why?
|
Color | 1 | 2012 | 298 | 0.020 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2013 | 944 | 0.020 |
Why?
|
Myocytes, Cardiac | 1 | 2019 | 1666 | 0.020 |
Why?
|
Cell Differentiation | 2 | 2019 | 11505 | 0.020 |
Why?
|
Time Factors | 1 | 2012 | 39953 | 0.020 |
Why?
|
Rats, Inbred Lew | 1 | 2012 | 1159 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2023 | 4574 | 0.020 |
Why?
|
Materials Testing | 1 | 2013 | 866 | 0.020 |
Why?
|
Tissue Donors | 1 | 2019 | 2334 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2023 | 4744 | 0.020 |
Why?
|
Animals | 5 | 2024 | 168083 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2024 | 10421 | 0.020 |
Why?
|
Rats | 2 | 2017 | 23713 | 0.020 |
Why?
|
Sciatic Nerve | 1 | 2012 | 618 | 0.020 |
Why?
|
Neoplasms | 1 | 2016 | 22125 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2024 | 15845 | 0.020 |
Why?
|
Heart | 1 | 2019 | 4431 | 0.020 |
Why?
|
Nerve Regeneration | 1 | 2012 | 796 | 0.020 |
Why?
|
Kinetics | 1 | 2012 | 6312 | 0.020 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2019 | 3200 | 0.010 |
Why?
|
Stem Cell Transplantation | 1 | 2012 | 1600 | 0.010 |
Why?
|
Stem Cells | 1 | 2015 | 3512 | 0.010 |
Why?
|
HEK293 Cells | 1 | 2012 | 4250 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2019 | 18217 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2013 | 11066 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2013 | 14676 | 0.010 |
Why?
|
Skin | 1 | 2012 | 4473 | 0.010 |
Why?
|
Mice | 1 | 2024 | 81324 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2016 | 7873 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2022 | 64670 | 0.010 |
Why?
|
Concepts
(144)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(53)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_